No Data
November 22nd A-share investment lightning rod︱Changguang Huaxin: Shareholders Guotou Chuangye Ningbo Fund, Yili Suxin, and Nanjing Daofeng plan to collectively reduce their shareholding by no more than 2.01%.
*Shenzhen Coship Electronics: Termination of the application for reorganization and pre-reorganization to the court.
Express News | Chengda Pharmaceutical: Shareholder Qianhai Shengtai plans to reduce their shareholding by no more than 4.22% of the company's shares.
Express News | Chengda Pharmaceuticals: The active pharmaceutical ingredient Daglielin has passed the CDE approval.
Chengda Pharmaceutical: Report for the third quarter of 2024
Chengda Pharmaceutical (301201.SZ) released its performance for the first three quarters, with a net income of 40.3928 million yuan, a decrease of 33.98%.
Chengda Pharmaceutical (301201.SZ) released the third quarter report of 2024, the company's revenue for the first three quarters is 2...
Chengda Pharmaceutical (301201.SZ): has cumulatively repurchased 2.10% of its shares.
Gelonghui October 10th | Chengda Pharmaceutical (301201.SZ) announced that as of September 30, 2024, the company has repurchased a total of 3,244,700 shares of the company through a repurchase special securities account in a centralized auction trading manner, accounting for 2.10% of the company's total share capital. The highest fill price was 22.21 yuan/share, the lowest fill price was 14.63 yuan/share, and the total trade amount was 57.0616 million yuan (excluding trading fees).
No Data
No Data